Cargando…

Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory

BACKGROUND: Following the WHO’s endorsement of GeneXpert MTB/RIF assay for tuberculosis diagnosis in 2010, Uganda’s ministry of health introduced the assay in its laboratory network in 2012. However, assessing the quality of the result produced from this technique is one of its major implementation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabugo, Joel, Namutebi, Joanita, Mujuni, Dennis, Nsawotebba, Andrew, Kasule, George William, Musisi, Kenneth, Kigozi, Edgar, Nyombi, Abdunoor, Lutaaya, Pius, Kangave, Fredrick, Joloba, Moses L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121318/ https://www.ncbi.nlm.nih.gov/pubmed/33989348 http://dx.doi.org/10.1371/journal.pone.0251691

Ejemplares similares

Impact of randomized blinded rechecking program on the performance of the AFB Microscopy Laboratory Network in Uganda: a decadal retrospective study
por: Nsawotebba, Andrew, et al.
Publicado: (2023)

Evaluating the effectiveness of Uganda’s Supranational TB Reference Laboratory quality management system training program
por: Dorothy, Nakiwala, et al.
Publicado: (2023)

Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017
por: Farra, Alain, et al.
Publicado: (2019)

Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
por: Bahizi, Gloria, et al.
Publicado: (2021)

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review
por: Mujuni, Dennis, et al.
Publicado: (2022)

Advancing proficiency testing for ultra in resource-limited settings using dried tube specimen: A study by SRL-Uganda
por: Kabugo, Joel, et al.
Publicado: (2023)

Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory
por: Dusthackeer, Azger, et al.
Publicado: (2015)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
por: Byanyima, Patrick, et al.
Publicado: (2022)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
por: Nalugwa, Talemwa, et al.
Publicado: (2020)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda
por: Kabahita, Jupiter Marina, et al.
Publicado: (2022)

Supranational Assessment of the Quality of Probiotics: Collaborative Initiative between Independent Accredited Testing Laboratories
por: Warzée, Jean-Pol, et al.
Publicado: (2021)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
por: Moussa, Husseiny Sh., et al.
Publicado: (2016)

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)

Effectiveness of thermal screening in detection of COVID-19 among truck drivers at Mutukula Land Point of Entry, Uganda
por: Nsawotebba, Andrew, et al.
Publicado: (2021)

Evaluation of GeneXpert MTB/RIF for detecting Mycobacterium tuberculosis in a hospital in China
por: Tang, Tingyu, et al.
Publicado: (2017)

GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens
por: Pang, Yu, et al.
Publicado: (2017)

GeneXpert(®) MTB/RIF assay with transbronchial lung cryobiopsy for Mycobacterium tuberculosis diagnosis
por: Sánchez-Cabral, Olivia, et al.
Publicado: (2020)

Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion
por: Jain, Jyoti, et al.
Publicado: (2021)

Quality of Sputum Specimen Samples Submitted for Culture and Drug Susceptibility Testing at the National Tuberculosis Reference Laboratory-Uganda, July-October 2013
por: Bulage, Lilian, et al.
Publicado: (2015)

The Virus Reference Laboratory
por: Dick, G. W. A., et al.
Publicado: (1958)

Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert(®) MTB/RIF assay
por: Rasool, Ghulam, et al.
Publicado: (2019)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Effect of two alternative methods of pooling sputum prior to testing for tuberculosis with genexpert MTB/RIF
por: Phuong, Nguyen Thi Bich, et al.
Publicado: (2019)

Assessment of GeneXpert MTB/RIF Performance by Type and Level of Health-Care Facilities in Nigeria
por: Gidado, Mustapha, et al.
Publicado: (2019)

Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand
por: Pongpeeradech, Nathakorn, et al.
Publicado: (2022)

The Value of GeneXpert MTB/RIF for Detection in Tuberculosis: A Bibliometrics-Based Analysis and Review
por: Li, Zhiyi
Publicado: (2022)

Comparison of GeneXpert and line probe assay for detection of Mycobacterium tuberculosis and rifampicin-mono resistance at the National Tuberculosis Reference Laboratory, Kenya
por: Aricha, S. A., et al.
Publicado: (2019)

Are virtues national, supranational, or universal?
por: van Oudenhoven, Jan Pieter, et al.
Publicado: (2014)

The Virus Reference Laboratory (Report)
por: Murray, H. G. S., et al.
Publicado: (1958)

GeneXpert MTB/RIF Outperforms Mycobacterial Culture in Detecting Mycobacterium tuberculosis from Salivary Sputum
por: Shi, Jin, et al.
Publicado: (2018)

Evaluation of stool GeneXpert MTB/RIF for the diagnosis of pulmonary tuberculosis among presumptive patients in Tanzania
por: Ngadaya, Esther, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jc84a2u71bkpr0q5jtsmfb44b2